{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:24:32Z","timestamp":1740806672874,"version":"3.38.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.mehy.2010.11.007","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T10:55:55Z","timestamp":1291114555000},"page":"417-420","source":"Crossref","is-referenced-by-count":1,"title":["Host factors may influence response to antiviral therapy in chronic hepatitis B virus infections"],"prefix":"10.1016","volume":"76","author":[{"given":"Oliver","family":"Schildgen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2010.11.007_b0005","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1177\/135965350601100614","article-title":"Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy","volume":"11","author":"Liaw","year":"2006","journal-title":"Antivir Ther"},{"key":"10.1016\/j.mehy.2010.11.007_b0010","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1086\/502978","article-title":"Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers","volume":"193","author":"Liu","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mehy.2010.11.007_b0015","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1517\/14712598.6.9.913","article-title":"New developments in the treatment of chronic hepatitis B","volume":"6","author":"Hadziyannis","year":"2006","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.mehy.2010.11.007_b0020","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1365-2893.2006.00748.x","article-title":"Improved outcome of chronic hepatitis B after heart transplantation by long-term antiviral therapy","volume":"13","author":"Potthoff","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.mehy.2010.11.007_b0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jcv.2006.08.021","article-title":"Nonresponse to adefovir: host or virus dependent?","volume":"37","author":"Schildgen","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.mehy.2010.11.007_b0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3748\/wjg.v13.i1.125","article-title":"Antiviral therapy and resistance with hepatitis B virus infection","volume":"13","author":"Tillmann","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.mehy.2010.11.007_b0035","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1128\/AAC.00840-07","article-title":"Novel lamivudine resistance","volume":"51","author":"Schildgen","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mehy.2010.11.007_b0040","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/00365520500319013","article-title":"Replacement of tenofovir with adefovir may result in reactivation of hepatitis B virus replication","volume":"41","author":"Schildgen","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.mehy.2010.11.007_b0045","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1097\/00002030-200411190-00014","article-title":"Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment","volume":"18","author":"Schildgen","year":"2004","journal-title":"Aids"},{"key":"10.1016\/j.mehy.2010.11.007_b0050","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJMoa051214","article-title":"Variant of hepatitis B virus with primary resistance to adefovir","volume":"354","author":"Schildgen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mehy.2010.11.007_b0055","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/jac\/dkm199","article-title":"Does pre-treatment with lamivudine prime for adefovir resistance of hepatitis B virus infection?","volume":"60","author":"Sirma","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.mehy.2010.11.007_b0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/135965350801300317","article-title":"Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutants","volume":"13","author":"Carrouee-Durantel","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.mehy.2010.11.007_b0065","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/522521","article-title":"Hepatitis B virus containing the I233V mutation in the polymerase reverse-transcriptase domain remains sensitive to inhibition by adefovir","volume":"196","author":"Curtis","year":"2007","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.mehy.2010.11.007_b0070","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S1386-6532(05)80008-3","article-title":"Resistance of human hepatitis B virus to reverse transcriptase inhibitors: from genotypic to phenotypic testing","volume":"34","author":"Durantel","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.mehy.2010.11.007_b0075","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2008.01.027","article-title":"Impact of hepatitis B virus rtA181V\/T mutants on hepatitis B treatment failure","volume":"48","author":"Villet","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.mehy.2010.11.007_b0080","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.bcp.2004.07.010","article-title":"Effective metabolism and long intracellular half life of the anti-hepatitis B agent adefovir in hepatic cells","volume":"68","author":"Ray","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2010.11.007_b0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.pharmthera.2006.04.009","article-title":"Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs","volume":"112","author":"Cascorbi","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.mehy.2010.11.007_b0090","first-page":"237","article-title":"Chemotherapy-induced resistance by ATP-binding cassette transporter genes","volume":"1775","author":"Gillet","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mehy.2010.11.007_b0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1128\/AAC.39.1.117","article-title":"Transport of 9-(2-phosphonomethoxyethyl)adenine across plasma membrane of HeLa S3 cells is protein mediated","volume":"39","author":"Cihlar","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mehy.2010.11.007_b0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0006-291X(91)91818-W","article-title":"Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte\/macrophages and peripheral blood lymphocytes","volume":"178","author":"Balzarini","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2010.11.007_b0105","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0006-2952(00)00512-8","article-title":"Interaction of guanine phosphonomethoxyalkyl derivatives with GMP kinase isoenzymes","volume":"60","author":"Krejcova","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2010.11.007_b0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0026-895X(25)08552-9","article-title":"A human T lymphoid cell variant resistant to the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl)adenine shows a unique combination of a phosphorylation defect and increased efflux of the agent","volume":"47","author":"Robbins","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.mehy.2010.11.007_b0115","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1128\/AAC.39.10.2304","article-title":"Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cells","volume":"39","author":"Robbins","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mehy.2010.11.007_b0120","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1128\/AAC.00138-06","article-title":"Intracellular metabolism and in vitro activity of tenofovir against hepatitis B virus","volume":"50","author":"Delaney","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mehy.2010.11.007_b0125","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s10541-005-0269-y","article-title":"Functional coupling between nucleoside diphosphate kinase of the outer mitochondrial compartment and oxidative phosphorylation","volume":"70","author":"Lipskaya","year":"2005","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.mehy.2010.11.007_b0130","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1134\/S0006297908030139","article-title":"Mitochondrial nucleoside diphosphate kinase: mode of interaction with the outer mitochondrial membrane and proportion of catalytic activity functionally coupled to oxidative phosphorylation","volume":"73","author":"Lipskaya","year":"2008","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.mehy.2010.11.007_b0135","doi-asserted-by":"crossref","first-page":"26198","DOI":"10.1074\/jbc.M803132200","article-title":"The nucleoside diphosphate kinase D (NM23-H4) binds the inner mitochondrial membrane with high affinity to cardiolipin and couples nucleotide transfer with respiration","volume":"283","author":"Tokarska-Schlattner","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2010.11.007_b0140","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jmb.2006.06.057","article-title":"Mitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients","volume":"361","author":"McKenzie","year":"2006","journal-title":"J Mol Biol"},{"key":"10.1016\/j.mehy.2010.11.007_b0145","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1074\/jbc.M309505200","article-title":"Assembly of respiratory complexes I, III, and IV into NADH oxidase supercomplex stabilizes complex I in Paracoccus denitrificans","volume":"279","author":"Stroh","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.mehy.2010.11.007_b0150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.mito.2008.01.002","article-title":"Nucleoside reverse transcriptase inhibitors (NRTIs)-induced expression profile of mitochondria-related genes in the mouse liver","volume":"8","author":"Desai","year":"2008","journal-title":"Mitochondrion"},{"key":"10.1016\/j.mehy.2010.11.007_b0155","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1126\/science.294.5550.2376","article-title":"Calcium signaling by HBx protein in hepatitis B virus DNA replication","volume":"294","author":"Bouchard","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.mehy.2010.11.007_b0160","doi-asserted-by":"crossref","first-page":"6798","DOI":"10.1128\/JVI.00154-08","article-title":"Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential","volume":"82","author":"Clippinger","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2010.11.007_b0165","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1128\/JVI.00172-07","article-title":"Hepatitis B virus X protein stimulates the mitochondrial translocation of Raf-1 via oxidative stress","volume":"81","author":"Chen","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2010.11.007_b0170","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0016-5085(03)00939-9","article-title":"Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase","volume":"125","author":"Angus","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mehy.2010.11.007_b0175","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1099\/vir.0.83659-0","article-title":"Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vector","volume":"89","author":"Lucifora","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.mehy.2010.11.007_b0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2006-939759","article-title":"In vitro models for studying hepatitis B virus drug resistance","volume":"26","author":"Zoulim","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.mehy.2010.11.007_b0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archinte.166.1.9","article-title":"Treatment of hepatitis B: who, when, and how?","volume":"166","author":"Wong","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.mehy.2010.11.007_b0190","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1128\/JVI.75.10.4771-4779.2001","article-title":"Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC)","volume":"75","author":"Das","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.mehy.2010.11.007_b0195","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1128\/JVI.02395-06","article-title":"Inhibition of hepatitis B virus polymerase by entecavir","volume":"81","author":"Langley","year":"2007","journal-title":"J Virol"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987710004706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987710004706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T09:08:59Z","timestamp":1740733739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987710004706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0306987710004706"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2010.11.007","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}